Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study

PURPOSE: The purpose of this study was to evaluate endocrine therapy and chemotherapy for first-line, maintenance, and second-line treatment of hormone receptor-positive HER-2-negative metastatic breast cancer (HR+HER-2-MBC) and the relationship between different treatment options and survival. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiuyue, Qiu, Juan, Lu, Qianrun, Ma, Yujin, Fang, Shu, Bu, Bing, Song, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360505/
https://www.ncbi.nlm.nih.gov/pubmed/35957911
http://dx.doi.org/10.3389/fonc.2022.873570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360505/
https://www.ncbi.nlm.nih.gov/pubmed/35957911
http://dx.doi.org/10.3389/fonc.2022.873570

Ejemplares similares